Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Hussain Almasmoum. (2021) The Roles of Transmembrane Mucins Located on Chromosome 7q22.1 in Colorectal Cancer. Cancer Management and Research 13, pages 3271-3280.
Read now
Read now
Adam J. Grippin, Elias J. Sayour & Duane A. Mitchell. (2017) Translational nanoparticle engineering for cancer vaccines. OncoImmunology 6:10.
Read now
Read now
Shilpa Gupta, Estrella Carballido & Mayer Fishman. (2011) Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments. OncoTargets and Therapy 4, pages 79-96.
Read now
Read now
Pamela E Constantinou, Brian P Danysh, Neeraja Dharmaraj & Daniel D Carson. (2011) Transmembrane mucins as novel therapeutic targets. Expert Review of Endocrinology & Metabolism 6:6, pages 835-848.
Read now
Read now
Antu K Dey & Indresh K Srivastava. (2011) Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens. Expert Review of Vaccines 10:2, pages 227-251.
Read now
Read now
Kashif Siddiqui & Laurence H Klotz. (2009) Emerging drugs for prostate cancer. Expert Opinion on Emerging Drugs 14:3, pages 455-470.
Read now
Read now
Choon-Kit Tang, Maria Katsara & Vasso Apostolopoulos. (2008) Strategies used for MUC1 immunotherapy: human clinical studies. Expert Review of Vaccines 7:7, pages 963-975.
Read now
Read now
Sue D Xiang, Karen Scalzo-Inguanti, Gabriela Minigo, Anthony Park, Charles L Hardy & Magdalena Plebanski. (2008) Promising particle-based vaccines in cancer therapy. Expert Review of Vaccines 7:7, pages 1103-1119.
Read now
Read now
Articles from other publishers (22)
Suresh Sulekha Dhanisha & Chandrasekharan Guruvayoorappan. (2023) Pathological Implications of Mucin Signaling in Metastasis. Current Cancer Drug Targets 23:8, pages 585-602.
Crossref
Crossref
Yi-Ru Pan, Chiao-En Wu, Wen-Kuan Huang, Ming-Huang Chen, Keng-Hsueh Lan & Chun-Nan Yeh. (2022) Chimeric immune checkpoint protein vaccines inhibit the tumorigenesis and growth of rat cholangiocarcinoma. Frontiers in Immunology 13.
Crossref
Crossref
Sanyog Jain, Kaisar Raza, Ashish Kumar Agrawal & Ankur Vaidya. 2021. Nanotechnology Applications for Cancer Chemotherapy. Nanotechnology Applications for Cancer Chemotherapy
515
545
.
Christian F. Singer, Georg Pfeiler, Michael Hubalek, Rupert Bartsch, Herbert Stöger, Angelika Pichler, Edgar Petru, Vesna Bjelic-Radisic, Richard Greil, Margaretha Rudas, Muy-Kheng Maria Tea, Viktor Wette, Andreas L. Petzer, Paul Sevelda, Daniel Egle, Peter C. Dubsky, Martin Filipits, Florian Fitzal, Ruth Exner, Raimund Jakesz, Marija Balic, Christoph Tinchon, Zsuzsanna Bago-Horvath, Sophie Frantal & Michael Gnant. (2020) Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34). European Journal of Cancer 132, pages 43-52.
Crossref
Crossref
Mei Guo, Chengzhong You & Jun Dou. (2018) Role of transmembrane glycoprotein mucin 1 (MUC1) in various types of colorectal cancer and therapies: Current research status and updates. Biomedicine & Pharmacotherapy 107, pages 1318-1325.
Crossref
Crossref
Boqi Hu, Juan Wang, Yingying Guo, Tanxiu Chen, Weihua Ni, Hongyan Yuan, Nannan Zhang, Fei Xie & Guixiang Tai. (2016) Pre-clinical toxicity and immunogenicity evaluation of a MUC1–MBP/BCG anti-tumor vaccine. International Immunopharmacology 33, pages 108-118.
Crossref
Crossref
Abhijit Bandyopadhyay, Tamalika Das & Sabina YeasminAbhijit Bandyopadhyay, Tamalika Das & Sabina Yeasmin. 2015. Nanoparticles in Lung Cancer Therapy - Recent Trends. Nanoparticles in Lung Cancer Therapy - Recent Trends
17
26
.
Ashutosh Barve, Wei Jin & Kun Cheng. (2014) Prostate cancer relevant antigens and enzymes for targeted drug delivery. Journal of Controlled Release 187, pages 118-132.
Crossref
Crossref
Rajesh K. Gupta. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
32
.
Luis Corrales-Rodriguez, Normand Blais & Denis Soulières. (2013) Vaccines in Non-Small Cell Lung Cancer. World Journal of Vaccines 03:01, pages 19-24.
Crossref
Crossref
David Roulois, Marc Grégoire & Jean-François Fonteneau. (2013) MUC1-Specific Cytotoxic T Lymphocytes in Cancer Therapy: Induction and Challenge. BioMed Research International 2013, pages 1-10.
Crossref
Crossref
RIVA KOVJAZIN, ANNA DUBNIK, GALIT HORN, NECHAMA I. SMORODINSKY, IZHAR HARDAN, MICHAEL YECHIEL SHAPIRA & LIOR CARMON. (2012) Autoantibodies against the signal peptide domain of MUC1 in patients with multiple myeloma: Implications for disease diagnosis and prognosis. Experimental and Therapeutic Medicine 3:6, pages 1092-1098.
Crossref
Crossref
Sean M. Geary, Caitlin D. Lemke, Yogita Krishnamachari & Aliasger K. Salem. 2012. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
391
421
.
David A Christian & Christopher A Hunter. (2012) Particle-mediated delivery of cytokines for immunotherapy. Immunotherapy 4:4, pages 425-441.
Crossref
Crossref
Nathalie Machluf & Ruth Arnon. (2012) Therapeutic MUC1-Based Cancer Vaccine Expressed in Flagella-Efficacy in an Aggressive Model of Breast Cancer. World Journal of Vaccines 02:03, pages 109-120.
Crossref
Crossref
Joseph G. Altin. 2012. Innovation in Vaccinology. Innovation in Vaccinology
135
178
.
Sarah R Goodyear & Hossein Borghaei. (2011) Lung cancer vaccines: a review of three ongoing trials. Clinical Investigation 1:6, pages 849-858.
Crossref
Crossref
Riva Kovjazin, Ilan Volovitz, Yulia Kundel, Eli Rosenbaum, Gal Medalia, Galit Horn, Nechama I. Smorodinsky, Baruch Brenner & Lior Carmon. (2011) ImMucin: A novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors. Vaccine 29:29-30, pages 4676-4686.
Crossref
Crossref
Folkert Steinhagen, Takeshi Kinjo, Christian Bode & Dennis M. Klinman. (2011) TLR-based immune adjuvants. Vaccine 29:17, pages 3341-3355.
Crossref
Crossref
Yogita Krishnamachari, Sean M. Geary, Caitlin D. Lemke & Aliasger K. Salem. (2010) Nanoparticle Delivery Systems in Cancer Vaccines. Pharmaceutical Research 28:2, pages 215-236.
Crossref
Crossref
A S Mall. (2008) Analysis of mucins: role in laboratory diagnosis. Journal of Clinical Pathology 61:9, pages 1018-1024.
Crossref
Crossref
Shuzi Zhang, Haihong Zhang, Heliang Shi, Xianghui Yu, Wei Kong & Wei Li. (2008) Induction of immune response and anti-tumor activities in mice with a DNA vaccine encoding human mucin 1 variable-number tandem repeats. Human Immunology 69:4-5, pages 250-258.
Crossref
Crossref